☆ 4.4 Article

Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation

OPHTHALMOLOGY AND THERAPY (2022)

Related references

Note: Only part of the references are listed.

Review Ophthalmology

Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration A Mixed-Methods Systematic Review

Mali Okada et al.

Summary: Nonadherence and nonpersistence significantly impact the treatment outcomes for patients with neovascular age-related macular degeneration (nAMD), necessitating further research to clarify contributing factors and improvement strategies. There is significant variation in definitions and rates of nonadherence and nonpersistence, with moderate certainty results highlighting some relevant factors. Factors such as treatment condition, baseline vision, and treatment response may influence nonadherence and nonpersistence.

OPHTHALMOLOGY (2021)

Add to Collection

Article Ophthalmology

Effects of the COVID-19 pandemic on neovascular age-related macular degeneration and response to delayed Anti-VEGF treatment

D. Y. Yeter et al.

Summary: The COVID-19 pandemic caused treatment delays for nAMD patients, leading to disease progression and visual impairment. More frequent anti-VEGF treatments and visits may be necessary until the disease stabilizes, despite improvements in OCT findings not always correlating with visual acuity success in the short term.

JOURNAL FRANCAIS D OPHTALMOLOGIE (2021)

Add to Collection

Article Ophthalmology

Artificial Intelligence (AI) Applications for Age-Related Macular Degeneration (AMD) and Other Retinal Dystrophies

Tatiana Perepelkina et al.

Summary: Artificial intelligence, including machine learning and deep learning, has yielded impressive results in various domains, especially in the field of medicine where it has been widely investigated. AI applications in ophthalmology have focused on diseases with high prevalence such as diabetic retinopathy, AMD, and glaucoma, showing promise for diagnosis, classification, and clinical management.

SEMINARS IN OPHTHALMOLOGY (2021)

Add to Collection

Article Ophthalmology

Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration

Mali Okada et al.

Summary: This study developed and validated terminology on patient nonadherence and nonpersistence to anti-vascular endothelial growth factor therapy for nAMD, aiming to provide a framework for assessing treatment nonadherence and nonpersistence over time and across different health settings.

JAMA OPHTHALMOLOGY (2021)

Add to Collection

Article Ophthalmology

Patient Mobility and Journey Distance as Risk Factors for Severe Visual Impairment: Real-Life Data Analysis of Treatment-naive Patients with nAMD under Intravitreal Aflibercept Therapy

Teresa Rauchegger et al.

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2020)

Add to Collection

Article Ophthalmology

Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic

Enrico Borrelli et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)

Add to Collection

Article Ophthalmology

Effect of the Duration of Intraretinal or Subretinal Fluid on the Response to Treatment in Undertreated Age-Related Macular Degeneration

Izumi Yoshida et al.

JOURNAL OF OPHTHALMOLOGY (2020)

Add to Collection

Article Health Care Sciences & Services

Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations

Amelia J. Averitt et al.

NPJ DIGITAL MEDICINE (2020)

Add to Collection

Article Ophthalmology

Outcomes of Eyes Lost to Follow-up with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Anti-Vascular Endothelial Growth Factor

Rebecca Russ Soares et al.

OPHTHALMOLOGY RETINA (2020)

Add to Collection

Article Ophthalmology

Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage

Reinhard Angermann et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)

Add to Collection

Article Ophthalmology

Telemedicine in the Management of Exudative Age-Related Macular Degeneration within an Integrated health care System

Matthew R. Starr et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)

Add to Collection

Article Ophthalmology

COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE

Maximilian Weiss et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)

Add to Collection

Article Ophthalmology

Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections

Anthony Obeid et al.

JAMA OPHTHALMOLOGY (2018)

Add to Collection

Article Health Care Sciences & Services

Multimorbidity associated with functional independence among community-dwelling older people: a cross-sectional study in Southern China

Xiao-Xiao Wang et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2017)

Add to Collection

Article Ophthalmology

METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Leah N. Kim et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)

Add to Collection

Article Ophthalmology

Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting

E. Boulanger-Scemama et al.

JOURNAL FRANCAIS D OPHTALMOLOGIE (2015)

Add to Collection

Article Ophthalmology

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

Frank G. Holz et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2015)

Add to Collection

Article Ophthalmology

Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

Frank G. Holz et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2013)

Add to Collection

Article Ophthalmology

Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life

Katharina M. Droege et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)

Add to Collection

Article Ophthalmology

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Jeffrey S. Heier et al.

OPHTHALMOLOGY (2012)

Add to Collection

Article Ophthalmology

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

David M. Brown et al.

OPHTHALMOLOGY (2009)

Add to Collection

Article Medicine, General & Internal

Ranibizumab for neovascular age-related macular degeneration

Philip J. Rosenfeld et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Add to Collection

Article Medicine, General & Internal

Use of SMS text messaging to improve outpatient attendance

SR Downer et al.

MEDICAL JOURNAL OF AUSTRALIA (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.